Steven Cohen Spectrum Pharmaceuticals Inc Transaction History

Point72 Asset Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$3.38 - $5.14 $320,508 - $487,400	-94,825 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$2.99 - $4.9 $283,526 - $464,642	94,825 New	94,825 $387,000
Q1 2019 May 15, 2019	SELL	$9.08 - $11.84 $4.9 Million - $6.38 Million	-539,200 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$6.39 - $16.99 $2.7 Million - $7.17 Million	421,900 Added 359.68%	539,200 $4.72 Million
Q3 2018 Nov 14, 2018	SELL	$16.52 - $24.82 $1.39 Million - $2.09 Million	-84,383 Reduced 41.84%	117,300 $1.97 Million
Q2 2018 Aug 14, 2018	BUY	$14.31 - $21.75 $2.89 Million - $4.39 Million	201,683 New	201,683 $4.23 Million

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.